Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Vaccinia 1Uterine Cervical Neoplasms 1Squamous Non-small Cell Lung Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma 1Neoplasms by Site 1Neoplasms by Histologic Type 1Melanoma 1Locally Advanced Pancreatic Cancer 1Gastric Adenocarcinoma 1Gallbladder Cancer Unresectable 1Diabetes Mellitus, Insulin-Dependent, 12 1Colonic Neoplasms 1Carcinoma, Pancreatic Ductal 1Brain Neoplasms 1Anal Cancer Metastatic 1

Interventions

Carboplatin 3durvalumab 2Tretinoin 2Paclitaxel 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1talazoparib 1sarilumab 1pexidartinib 1pertuzumab 1pembrolizumab 1patritumab 1olaparib 1niraparib 1neratinib 1ganitumab 1dostarlimab 1cemiplimab 1abemaciclib 1Trastuzumab 1Standard of Care 1STA 9090 1SGN-LIV1A 1Pemetrexed 1MK 2206 1Letrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × 130-nm albumin-bound paclitaxel × 30 days × Clear all
NCT07618793 2026-06-01

Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

Xuanwu Hospital, Beijing

Phase 2 Not yet recruiting
60 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡